2Andorfer CA, Necela BM, Thompson EA, et al. MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer. Trends Mol Med, 2011, 17(6):313-9.
3Yu F, Yao H, Zhu P, et al. Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell, 2007, 131(6): i 109-23.
4Png KJ, Yoshida M, Zhang XH, et al. MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev, 2011, 25(3): 226-31.
5Shi W, Gerster K, Alajez NM, et al. MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res, 2011, 71(8): 2926-37.
6Guo W J, Zeng MS, Yadav A, et al. Mel- 18 acts as a tumor suppressor by repressing Bmi-I expression and down- regulating Akt activity in breast cancer cells. Cancer Res, 2007, 67(11): 5083-9.
7Kawazu M, Saso K, Tong KI, et al. Histone demethylaseJMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLoS One, 2011, 6(3): el 7830.
8Kawai H, Li H, Chun P, et al. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells. Oncogene, 2002, 21(50): 7730-9.
9Chen C, Bhalala HV, Qiao H, et al. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene, 2002, 21 (43): 6567-72.
10Zhao D, Zheng HQ, Zhou Z, et al. The Fbw7 tumor sup- pressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation. Cancer Res, 2010, 70(11): 4728-38.
